戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1     Here we describe a simple mouse model of oropharyngeal candidiasis.
2 ly induce EGFR phosphorylation during murine oropharyngeal candidiasis.
3 1p-N) protects mice against disseminated and oropharyngeal candidiasis.
4 otherapy, and smoking were key predictors of oropharyngeal candidiasis.
5 tion, and fungal burden in a murine model of oropharyngeal candidiasis.
6 m the fluconazole-treated AIDS patients with oropharyngeal candidiasis.
7  method was used to screen for resistance in oropharyngeal candidiasis.
8 virus (HIV)-infected patients with recurrent oropharyngeal candidiasis.
9 ard Candida albicans, the causative agent of oropharyngeal candidiasis.
10 cted family of two children with symptomatic oropharyngeal candidiasis and a mother with asymptomatic
11 isingly, Arid5a (-/-) mice were resistant to oropharyngeal candidiasis and systemic candidiasis, simi
12 nic, clinically manifesting most commonly as oropharyngeal candidiasis and vulvovaginal candidiasis (
13 chanisms are expected for protection against oropharyngeal candidiasis, anti-Candida host defense mec
14                             Moreover, during oropharyngeal candidiasis, Arid5a is elevated within the
15 ing identified CD4 cell count and history of oropharyngeal candidiasis as key predictors of salivary
16 xamine the question of strain specificity in oropharyngeal candidiasis associated with human immunode
17 adiation for head and neck cancer to develop oropharyngeal candidiasis due to C. glabrata.
18 , while the comparison group (n = 39) had no oropharyngeal candidiasis during that period.
19 nts with a self-reported history of clinical oropharyngeal candidiasis during the previous 2 years co
20 lbicans that has been recently implicated in oropharyngeal candidiasis in human immunodeficiency viru
21 ogy of which mimics that of pseudomembranous oropharyngeal candidiasis in humans.
22          Furthermore, E. faecalis aggravates oropharyngeal candidiasis in mice.
23                       The pathophysiology of oropharyngeal candidiasis in patients infected with huma
24 andida dubliniensis has been associated with oropharyngeal candidiasis in patients infected with huma
25 w 200 cells/ microl) and positive history of oropharyngeal candidiasis in predicting salivary SLPI le
26 rotein may serve as an indicator of previous oropharyngeal candidiasis infection among immunosuppress
27                                              Oropharyngeal candidiasis is a frequent cause of morbidi
28 these cytokines in immune protection against oropharyngeal candidiasis is still incompletely understo
29        One important line of defense against oropharyngeal candidiasis is the oral microbiota that pr
30                                              Oropharyngeal candidiasis (OPC [thrush]) is an opportuni
31                                              Oropharyngeal candidiasis (OPC) caused by Candida albica
32             The disproportionate increase in oropharyngeal candidiasis (OPC) compared with systemic a
33 ast that has been increasingly implicated in oropharyngeal candidiasis (OPC) in human immunodeficienc
34 -17 receptor (IL-17R) is required to prevent oropharyngeal candidiasis (OPC) in mice and humans.
35                                              Oropharyngeal candidiasis (OPC) is a common opportunisti
36                                              Oropharyngeal candidiasis (OPC) is a common oral opportu
37                                              Oropharyngeal candidiasis (OPC) is among the most common
38                                              Oropharyngeal candidiasis (OPC) is an opportunistic fung
39                                              Oropharyngeal candidiasis (OPC) is an opportunistic infe
40                                     Isolated oropharyngeal candidiasis (OPC) was the most common pres
41                                              Oropharyngeal candidiasis (OPC), as opposed to vulvovagi
42 e immunity to Candida albicans, particularly oropharyngeal candidiasis (OPC), but essential downstrea
43                                              Oropharyngeal candidiasis (OPC), caused by Candida albic
44                                              Oropharyngeal candidiasis (OPC), caused by Candida albic
45                                              Oropharyngeal candidiasis (OPC), caused by the commensal
46                                              Oropharyngeal candidiasis (OPC), the most common oral in
47 ungus Candida albicans is the major cause of oropharyngeal candidiasis (OPC).
48 p as an immunogenic protein expressed during oropharyngeal candidiasis (OPC).
49 een described as the infecting organism with oropharyngeal candidiasis (OPC).
50 The commensal fungus Candida albicans causes oropharyngeal candidiasis (OPC; thrush) in settings of i
51                                              Oropharyngeal candidiasis (OPC; thrush) is an opportunis
52  human fungal pathogen that can cause severe oropharyngeal candidiasis (oral thrush) in susceptible h
53 S patients receiving fluconazole therapy for oropharyngeal candidiasis over a 2-year period were eval
54 and reduced interleukin-17 signalling during oropharyngeal candidiasis, resulting in more severe dise
55 tients with disseminated candidiasis (DC) or oropharyngeal candidiasis than controls.
56                                              Oropharyngeal candidiasis, typically caused by Candida a
57                    By using a mouse model of oropharyngeal candidiasis we found that IL-17A and IL-17
58 eficiency virus (HIV)-infected patients with oropharyngeal candidiasis, we identified three patients
59     At week 7 of his radiation, he developed oropharyngeal candidiasis, which was treated with 200 mg
60                             Most episodes of oropharyngeal candidiasis with trailing-endpoint isolate